Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
SANUWAVE HealthSNWV -2.67%29 Equity-to-Asset is 0.08 as of Jun. 2026. GuruFocus rates SNWV with a GF Score™ of 29/100 and a GF Value™ of $13.08 (Possible Value Trap). The stock has 7 warning signs investors should review. Among 851 Medical Devices & Instruments companies, SANUWAVE Health ranks worse than 91.42% on this metric.
Equity to Asset ratio is calculated as total stockholders equity divided by total asset. SANUWAVE Health's Total Stockholders Equity for the quarter that ended in Jun. 2026 was $2.79 Mil. SANUWAVE Health's Total Assets for the quarter that ended in Jun. 2026 was $36.61 Mil.
Therefore, SANUWAVE Health's Equity to Asset Ratio for the quarter that ended in Jun. 2026 was 0.08.
The historical rank and industry rank for SANUWAVE Health's Equity-to-Asset or its related term are showing as below:
SNWV'
s Equity-to-Asset Range Over the Past 10 Years
Min: -18.6 Med: -2.48 Max: 0.08
Current: 0.08
During the past 13 years, the highest Equity to Asset Ratio of SANUWAVE Health was 0.08. The lowest was -18.60. And the median was -2.48.
SNWV's Equity-to-Asset is ranked worse than 91.42% of 851
companies
in the Medical Devices & Instruments industry
Industry Median: 0.64
vs SNWV: 0.08
SANUWAVE Health (NAS:SNWV) Equity-to-Asset Explanation
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
SANUWAVE Health Equity-to-Asset Related Terms
SANUWAVE Health Equity-to-Asset Historical Data
* Premium members only.
The historical data trend for SANUWAVE Health's Equity-to-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SNWV vs NSPR, PAVM, ELUT: Equity-to-Asset Comparison
For the Medical Devices subindustry, SANUWAVE Health's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
SANUWAVE Health Equity-to-Asset vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, SANUWAVE Health's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where SANUWAVE Health's Equity-to-Asset falls into.
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
SANUWAVE Health's Equity to Asset Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SANUWAVE Health (SNWV) has a Equity-to-Asset of 0.08 as of Jun. 2026. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on SANUWAVE Health and its competitors. According to the industry distribution chart, SANUWAVE Health ranks #778 out of 851 companies in the Medical Devices & Instruments industry, placing it in the top 91.4%.
Is SANUWAVE Health's Equity-to-Asset too high?
SANUWAVE Health's current Equity-to-Asset is 0.08. The Medical Devices & Instruments industry median Equity-to-Asset is 0.64. SANUWAVE Health's value of 0.08 is 87.5% below this industry median. Based on the distribution chart, SANUWAVE Health ranks #778 out of 851 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, SANUWAVE Health has a GF Score™ of 29/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does SANUWAVE Health's Equity-to-Asset compare to NSPR and PAVM?
According to the Medical Devices & Instruments industry distribution chart, SANUWAVE Health ranks #778 out of 851 companies for Equity-to-Asset. This places SANUWAVE Health in the lower half of its industry. The industry median Equity-to-Asset is 0.64. SANUWAVE Health's value of 0.08 is 87.5% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for a Medical Devices & Instruments company?
The median Equity-to-Asset among Medical Devices & Instruments companies is 0.64, based on 851 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. SANUWAVE Health's current Equity-to-Asset of 0.08 is 87.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on SANUWAVE Health and its competitors. For the Medical Devices & Instruments industry, the median Equity-to-Asset is 0.64 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. SANUWAVE Health's current Equity-to-Asset is 0.08. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SANUWAVE Health stock overvalued right now?
Based on GuruFocus' analysis, SANUWAVE Health (SNWV) is currently considered Possible Value Trap. The stock's GF Value™ is $13.08, compared to a current price of $4.39 — trading 66.4% below its estimated fair value. The current Equity-to-Asset is 0.08 and 87.5% below the Medical Devices & Instruments industry median of 0.64. SANUWAVE Health's overall GF Score™ is 29/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For SANUWAVE Health (SNWV), the current Equity-to-Asset is 0.08 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is SANUWAVE Health (SNWV) Overvalued in 2026?
Based on GuruFocus' analysis, SANUWAVE Health stock appears to be undervalued.
The current stock price of $4.39 is trading 66.4% below its estimated GF Value™ of $13.08.
GuruFocus considers SANUWAVE Health to be Possible Value Trap.
Key valuation signals for SNWV:
Equity-to-Asset: 0.08
GF Value™: $13.08 vs. price of $4.39 (66.4% below fair value)
Industry Position: 87.5% below the Medical Devices & Instruments median (#778 of 851)
No single metric tells the full story. See the SNWV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
SANUWAVE Health Inc is a medical device company providing directed energy products into the wound care space. It is focused on the commercialization of its patented regenerative medicine utilizing noninvasive ultrasound or shockwaves to produce a biological response promoting the repair and regeneration of tissue, musculoskeletal, and vascular structures. Sanuwave's patented, FDA-cleared, and commercialised product is the UltraMIST system, which is used to treat a variety of acute and chronic wounds using ultrasound technology. The company operates in one reportable segment, the design and sale of medical devices. Geographically, the company generates revenue mainly from the United States.
29GF Score
Get the complete analysis for SNWV
Equity-to-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SNWV has been successfully added to your 
